Biohazard Bag Market Synopsis
Biohazard Bag Market Size Was Valued at USD 449.07 Million in 2023 and is Projected to Reach USD 785.52 Million by 2032, Growing at a CAGR of 6.41% From 2024-2032.
A biohazard bag, also referred to as a biohazardous waste bag or infectious waste bag, is a specifically designed bag utilized for gathering, moving, and getting rid of biohazardous materials. These bags play a crucial role in the safe disposal of infectious waste in different environments.
- Biohazard bags play an important role in stopping infections from spreading by holding and getting rid of infectious materials, lowering the chances of passing on infections to healthcare workers, patients, and the general public.
- These bags shield healthcare workers from dangerous substances, upholding a secure atmosphere in healthcare facilities and research environments. Adhering to regulations regarding infection control and hazardous waste disposal helps minimize the likelihood of outbreaks and environmental contamination.
- Appropriate handling of infectious waste encourages sustainable waste management techniques and decreases the possibility of unauthorized dumping.
- Utilizing biohazard bags can also reduce the chance of legal action by showing a dedication to safety and controlling infections. In general, biohazard bags improve patient safety, assist in research and development, and are crucial in advancing medical knowledge and creating new treatments.
Top Active Players Involved Are:
BioMedical Waste Solutions LLC (USA), American Plastics Co. (USA), International Plastics Inc. (USA), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (USA), Transcendia Inc. (USA), Abdos Labtech Pvt. Ltd. (India), Champion Plastics (USA), Medline Industries, Inc. (USA), Global Packaging Solutions (USA), Dana Poly Inc (USA), VWR International, LLC. (USA), Daniels Sharpsmart Inc. (USA), SP Bel-Art (USA), Lithey Inc. (USA), Thomas Scientific (USA), Stericycle (USA), Heathrow Scientific (USA), Harbour Group (SP Bel-Art) (USA), Inteplast Group Corporation (Minigrip, LLC) (USA), Clean Harbors Inc. (USA), Bel-Art SP Scienceware (USA), TufPak (USA), Dynalon (USA), Desco Medical (USA), and Other Active Players.
Biohazard Bag Market Trend Analysis
Increasing Amount of Healthcare Waste
- The biohazard bag sector is experiencing growth as a result of the increase in healthcare waste generated by the expanding healthcare industry, increased medical procedures, widespread adoption of single-use products, infectious diseases, and stringent regulations.
- The healthcare industry's fast growth, spurred by a growing elderly population and medical progress, leads to an increase in waste, such as infectious and pharmaceutical waste.
- Disposable medical items are utilized to decrease the chances of infection, resulting in an increase in waste. Health crises such as COVID-19 lead to a greater necessity for specialized waste disposal, resulting in a higher demand for biohazard bags.
- Increased regulations from groups like the WHO and CDC emphasize the significance of correct healthcare waste management to prevent legal troubles. With a growing emphasis on healthcare-associated infections, the sector is giving importance to biohazard bags for the containment and disposal of infectious waste.
Rapidly Growing E-Commerce Sales Channel
- E-commerce offers benefits to biohazard bag manufacturers. It provides global accessibility, reduces distribution costs by eliminating intermediaries, and enhances the customer experience with personalized shopping.
- Additionally, e-commerce platforms offer valuable data insights on customer behaviour and preferences. Early adoption of e-commerce can give manufacturers a competitive edge over traditional offline players.
- Opportunities for biohazard bag manufacturers in e-commerce include utilizing various social media platforms to reach healthcare customers. Subscription-based models can also boost customer loyalty and generate recurring revenue for manufacturers.
- Manufacturers can sell biohazard bags directly to consumers, including individuals and small businesses, through their own e-commerce websites or platforms.
Source: Company Database
- In 2018, the global retail e-commerce sales were recorded at 2.9 trillion U.S. Dollar. In 2023, global retail e-commerce sales reached an estimated 5.8 trillion U.S. dollars.
Biohazard Bag Market Segment Analysis:
Biohazard Bag market is segmented on the basis of Material Type, Capacity Type, and End-user.
By Capacity Type, less than 15 gallons Segment Is Expected to Dominate the Market During the Forecast Period
There are three segments by capacity type such as less than 15 gallons, 16 gallons-30 gallons, and above 30 gallons. Among these, the less than 15-gallon segment is expected to dominate the market during the forecast period.
- Biohazard bags under 15 gallons are adaptable and can be used in various healthcare settings such as medical offices, clinics, and dental offices. They are the top choice for efficiently handling small amounts of biohazardous waste, particularly in ambulatory care facilities and diagnostic labs.
- Smaller bags can provide convenience, portability, and cost-efficiency in contrast to larger bags, making them essential for facilities with restricted budgets. These bags are designed to comply with regulations and ensure safe handling and disposal of biohazardous waste.
- The rise in popularity of home healthcare has also led to a higher need for these bags because they are well-suited for small spaces. Easily accessible and simple to obtain, companies are now more interested in creating and promoting biohazard bags that hold less than 15 gallons, resulting in a range of choices in the market.
- The strong need for these bags in different healthcare environments underscores their significance and superiority in effectively handling biohazardous waste.
By End-user, Hospitals, Clinics, & Diagnostic Lab Segment Held the Largest Share In 2023
There are three segments by end-user such as hospitals, clinics, & diagnostic lab, home & ambulatory care, and pharmaceutical & biopharmaceutical industries. Among these, hospitals, clinics, & diagnostic lab segment held the largest share in 2023.
- Hospitals, clinics, and diagnostic labs generate significant quantities of biohazardous waste that must be appropriately discarded in biohazard bags. OSHA, CDC, and other organizations closely oversee these regulations for infection control and waste management reasons.
- Biohazard bags play a main role in preventing the transmission of infections from patients with contagious diseases, which helps lower the risk for healthcare workers, patients, and the environment.
- These bags are often used for waste disposal, transporting samples, holding fluids, and for cleaning tasks. The high number of medical facilities results in a higher demand for biohazard bags, driven by healthcare workers' emphasis on infection control protocols. Different types of biohazard bags are available to fulfill specific needs.
- Government initiatives and financial aid also play a role in promoting infection control and waste management procedures, hence increasing the demand for biohazard bags. The significance of biohazard bags in reducing the spread of infection is emphasized by the high volume of patients in these environments.
Biohazard Bag Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast Period
- In North America, specifically in the United States, stringent guidelines exist for handling biohazardous waste which leads to a high demand for biohazard bags. In healthcare and research settings, proper waste management is necessary due to the high rates of infectious diseases in the region.
- Due to a strong healthcare system and pharmaceutical industry, there is an increased demand for biohazard bags. Healthcare workers focus on infection control, increasing demand.
- Key players in the market are present in North America to fulfill the market needs. Government funding aids in supporting medical and biotechnology research, leading to a greater demand for these services. The area's significant disposable revenue enables the purchase of top-notch biohazard bags.
- A well-developed distribution system enables convenient availability, while a strong emphasis on environmentally friendly choices boosts consumer interest. In North America, the demand for biohazard bags is driven by strict regulations, high levels of disease, infrastructure, strong industry, government backing, and environmental issues.
Biohazard Bag Market Active Players
- BioMedical Waste Solutions LLC (USA)
- American Plastics Co. (USA)
- International Plastics Inc. (USA)
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (USA)
- Transcendia Inc. (USA)
- Abdos Labtech Pvt. Ltd. (India)
- Champion Plastics (USA)
- Medline Industries, Inc. (USA)
- Global Packaging Solutions (USA)
- Dana Poly Inc (USA)
- VWR International, LLC. (USA)
- Daniels Sharpsmart Inc. (USA)
- SP Bel-Art (USA)
- Lithey Inc. (USA)
- Thomas Scientific (USA)
- Stericycle (USA)
- Heathrow Scientific (USA)
- Harbour Group (SP Bel-Art) (USA)
- Inteplast Group Corporation (Minigrip, LLC) (USA)
- Clean Harbors Inc. (USA)
- Bel-Art SP Scienceware (USA)
- TufPak (USA)
- Dynalon (USA)
- Desco Medical (USA), and Other Active Players.
Key Industry Developments in the Biohazard Bag Market:
- In August 2023, Stericycle, Inc. announced the launch of re-engineered SafeDrop™ Sharps Mail Back and CsRx® Controlled Substance Wastage containers. These one-gallon containers offer a contemporary design, improved ease of use, and sustainability. SafeDrop™ containers help healthcare providers manage sharps waste effectively, while CsRx® containers prevent diversion of controlled substance waste and secure disposal.
Global Biohazard Bag Market
|
Base Year:
|
2023
|
Forecast Period:
|
2024-2032
|
Historical Data:
|
2017 to 2023
|
Market Size in 2023:
|
USD 449.07 Mn.
|
Forecast Period 2024-32 CAGR:
|
6.41 %
|
Market Size in 2032:
|
USD 785.52 Mn.
|
Segments Covered:
|
By Material Type
|
|
By Capacity Type
|
- Less than 15 gallons
- 16 gallons-30 gallons
- Above 30 gallons
|
By End-user
|
- Hospitals, Clinics, & Diagnostic Lab
- Home & Ambulatory Care
- Pharmaceutical & Biopharmaceutical Industries
|
By Region
|
- North America (U.S., Canada, Mexico)
- Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
- Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
- Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
- Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
- South America (Brazil, Argentina, Rest of SA)
|